Thierry Petit

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

Élisa Gobbini, Monia Ezzalfani, Véronique Dièras et al. · European Journal of Cancer · 2018 · 281 citations

Medicine, Biostatistics, Oncology +17

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis

Arlindo R. Ferreira, Antonio Di Meglio, Barbara Pistilli et al. · Annals of Oncology · 2019 · 223 citations · Full text

Medicine, Endocrinology, Oncology +15

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

Amélie Darlix, G. Louvel, Julien Fraisse et al. · British Journal of Cancer · 2019 · 221 citations · Full text

Medicine, Oncology, Breast Oncology +15

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Hervé Bonnefoi, Saskia Litière, Martine Piccart et al. · Annals of Oncology · 2014 · 206 citations · Full text

Medicine, Oncology, Breast Oncology +13